Download PDF
1 / Pages

Other users also viewed these articles

Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later? Raffaele Brustia; Mohamed Bouattour; Manon Allaire; Marie Lequoy; Clémence Hollande; Hélène Regnault; Lorraine Blaise; Nathalie Ganne-Carrié; Valérie Vilgrain; Edouard Larrey; Chetana Lim; Olivier Scatton; Sanaa El Mouhadi; Violaine Ozenne; François Paye; Pierre Balladur; Anthony Dohan; Pierre-Philippe Massault; Stanislas Pol; Marco Dioguardi Burgio; Ailton Sepulveda; Francois Cauchy; Alain Luciani; Daniele Sommacale; Vincent Leroy; Julien Calderaro; Francoise Roudot-Thoraval; Jean-Charles Nault; Giuliana Amaddeo;
Ann Hepatol. 2023;28:
Prognostic factors influencing outcomes in hepatocellular carcinoma patients undergoing selective internal radiation therapy Maria Stella Franzè; Paul Vigneron; Anna Sessa; Carlo Saitta; Julia Chalaye; Vania Tacher; Alain Luciani; Hélène Regnault; Ancuta Bejan; Rami Rhaiem; Daniele Sommacale; Vincent Leroy; Raffaele Brustia; Giovanni Raimondo; Giuliana Amaddeo;
10.1016/j.aohep.2024.101539
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC Federico Piñero; Margarita Anders; Carla Bermudez; Ezequiel Demirdjian; Adriana Varón; Ana Palazzo; Jorge Rodriguez; Oscar Beltrán; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Norberto Tamagnone; Virginia Reggiardo; Hugo Cheinquer; Alexandre Araujo; Diego Arufe; Juan Ignacio Marín; Natalia Ratusnu; Estela Manero; Daniela Perez; Marina Villa; Federico Orozco; Dolores Murga; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;
Ann Hepatol. 2023;28: